Fairmount Funds Management LLC

13F Holdings History for Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN)

Symbol: VRDN on Nasdaq
Investment type: Equity / Common Stock, $0.01 par value
Latest Disclosed Ownership: 16M shares
Security Ownership: 15.1%

Shares, Excluding Options vs Price

Value, Excluding Options

Fairmount Funds Management LLC ownership in Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value (VRDN)

2025-10-27 - Fairmount Funds Management LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 16M shares of Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value (VRDN). This represents 15.1% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Fairmount Funds Management LLC	15.14%		$346M	16M			$21.58	13D/A	10/23/2025	27 Oct 2025 16:31:36

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	6.72%		$74.7M	3.46M			$21.58	Q3 2025
6/30/2025	6.27%	+0.03%	$48.4M	3.46M	+14,100	+0.41%	$13.98	Q2 2025
3/31/2025	7.21%		$46.4M	3.45M			$13.48	Q1 2025
12/31/2024	6.57%		$66.1M	3.45M			$19.17	Q4 2024
9/30/2024	6.36%	+2.95%	$78.4M	3.45M	+1,600,000	+86.7%	$22.75	Q3 2024
6/30/2024	2.71%		$24M	1.85M			$13.01	Q2 2024
3/31/2024	3.52%	+0.88%	$32.3M	1.85M	+476,190	+34.8%	$17.51	Q1 2024
12/31/2023	3.15%		$29.8M	1.37M			$21.78	Q4 2023
9/30/2023	2.53%		$21M	1.37M			$15.34	Q3 2023
6/30/2023	4.59%		$32.6M	1.37M			$23.79	Q2 2023
3/31/2023	5.99%		$34.8M	1.37M			$25.44	Q1 2023
12/31/2022	6.35%		$40M	1.37M			$29.21	Q4 2022
9/30/2022	4.94%	+1.53%	$28.1M	1.37M	+425,531	+45.1%	$20.51	Q3 2022
6/30/2022	2.5%		$10.9M	944K			$11.57	Q2 2022
3/31/2022	4.13%		$17.5M	944K			$18.49	Q1 2022
12/31/2021	6.15%		$18.7M	944K			$19.77	Q4 2021
9/30/2021	5.65%	+6.15%	$15.5M	944K	+909,000	+2590%	$16.45	Q3 2021
6/30/2021	0.26%		$642K	35.1K			$18.29	Q2 2021
3/31/2021	0.24%	+0.21%	$581K	35.1K	+35,092	NEW	$16.56	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.